nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—KCNMA1—blood vessel—melanoma	0.0521	0.129	CbGeAlD
Bendroflumethiazide—TPMT—retina—melanoma	0.0295	0.0731	CbGeAlD
Bendroflumethiazide—KCNMA1—eye—melanoma	0.0277	0.0686	CbGeAlD
Bendroflumethiazide—KCNMA1—retina—melanoma	0.0275	0.068	CbGeAlD
Bendroflumethiazide—CA2—hair follicle—melanoma	0.0273	0.0677	CbGeAlD
Bendroflumethiazide—TPMT—mammalian vulva—melanoma	0.0236	0.0585	CbGeAlD
Bendroflumethiazide—CA4—neck—melanoma	0.0221	0.0548	CbGeAlD
Bendroflumethiazide—CA1—eye—melanoma	0.0211	0.0521	CbGeAlD
Bendroflumethiazide—CA2—neck—melanoma	0.0184	0.0454	CbGeAlD
Bendroflumethiazide—TPMT—head—melanoma	0.0169	0.0419	CbGeAlD
Bendroflumethiazide—KCNMA1—head—melanoma	0.0157	0.039	CbGeAlD
Bendroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC17A5—melanoma	0.0142	0.0327	CbGpPWpGaD
Bendroflumethiazide—CA2—eye—melanoma	0.0137	0.0338	CbGeAlD
Bendroflumethiazide—CA2—retina—melanoma	0.0135	0.0335	CbGeAlD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—RAI1—melanoma	0.0124	0.0286	CbGpPWpGaD
Bendroflumethiazide—CA1—head—melanoma	0.012	0.0296	CbGeAlD
Bendroflumethiazide—CA2—skin of body—melanoma	0.0119	0.0294	CbGeAlD
Bendroflumethiazide—TPMT—lymph node—melanoma	0.0118	0.0293	CbGeAlD
Bendroflumethiazide—KCNMA1—lymph node—melanoma	0.011	0.0273	CbGeAlD
Bendroflumethiazide—CA2—mammalian vulva—melanoma	0.0108	0.0268	CbGeAlD
Bendroflumethiazide—KCNMA1—Nitric oxide stimulates guanylate cyclase—NOS2—melanoma	0.00955	0.022	CbGpPWpGaD
Bendroflumethiazide—CA4—head—melanoma	0.00935	0.0231	CbGeAlD
Bendroflumethiazide—TPMT—Metapathway biotransformation—AKR1B10—melanoma	0.00919	0.0211	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—SKI—melanoma	0.00882	0.0203	CbGpPWpGaD
Bendroflumethiazide—CA1—lymph node—melanoma	0.00837	0.0207	CbGeAlD
Bendroflumethiazide—CA2—head—melanoma	0.00775	0.0192	CbGeAlD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—ARNT—melanoma	0.0074	0.017	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—PAX4—melanoma	0.00715	0.0164	CbGpPWpGaD
Bendroflumethiazide—Drug interaction—Carmustine—melanoma	0.00667	0.0414	CcSEcCtD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC15A2—melanoma	0.0066	0.0152	CbGpPWpGaD
Bendroflumethiazide—CA4—lymph node—melanoma	0.00654	0.0162	CbGeAlD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCB5—melanoma	0.00638	0.0147	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC17A5—melanoma	0.00635	0.0146	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—ETS1—melanoma	0.00615	0.0141	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—melanoma	0.0059	0.0136	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC6A11—melanoma	0.00577	0.0133	CbGpPWpGaD
Bendroflumethiazide—CA2—lymph node—melanoma	0.00543	0.0134	CbGeAlD
Bendroflumethiazide—KCNMA1—Hemostasis—CEACAM1—melanoma	0.0053	0.0122	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—SLC6A11—melanoma	0.00517	0.0119	CbGpPWpGaD
Bendroflumethiazide—Diabetes mellitus—Carmustine—melanoma	0.00517	0.0321	CcSEcCtD
Bendroflumethiazide—Vascular purpura—Temozolomide—melanoma	0.00485	0.0301	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—CYP17A1—melanoma	0.00482	0.0111	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—CYP17A1—melanoma	0.00475	0.0109	CbGpPWpGaD
Bendroflumethiazide—Thirst—Temozolomide—melanoma	0.00456	0.0283	CcSEcCtD
Bendroflumethiazide—Purpura—Temozolomide—melanoma	0.00451	0.028	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ARL2—melanoma	0.00443	0.0102	CbGpPWpGaD
Bendroflumethiazide—Drug interaction—Docetaxel—melanoma	0.00429	0.0266	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Carmustine—melanoma	0.00409	0.0254	CcSEcCtD
Bendroflumethiazide—TPMT—Biological oxidations—CYP1B1—melanoma	0.00406	0.00933	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metapathway biotransformation—CYP1B1—melanoma	0.004	0.0092	CbGpPWpGaD
Bendroflumethiazide—Hypokalaemia—Temozolomide—melanoma	0.00395	0.0245	CcSEcCtD
Bendroflumethiazide—Hypotension—Vemurafenib—melanoma	0.0039	0.0242	CcSEcCtD
Bendroflumethiazide—KCNMA1—Platelet homeostasis—NOS2—melanoma	0.00372	0.00855	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Vemurafenib—melanoma	0.00363	0.0225	CcSEcCtD
Bendroflumethiazide—Constipation—Vemurafenib—melanoma	0.00357	0.0222	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Temozolomide—melanoma	0.00346	0.0214	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC15A2—melanoma	0.00335	0.00771	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC17A5—melanoma	0.00323	0.00743	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—GNA11—melanoma	0.00319	0.00734	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—GRIN2A—melanoma	0.00316	0.00726	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—HDAC2—melanoma	0.003	0.0069	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Vemurafenib—melanoma	0.003	0.0186	CcSEcCtD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—GNAQ—melanoma	0.00297	0.00683	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00293	0.00674	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Vemurafenib—melanoma	0.00286	0.0177	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—KIT—melanoma	0.00284	0.00653	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Vemurafenib—melanoma	0.00276	0.0171	CcSEcCtD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—NGFR—melanoma	0.00274	0.0063	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ACER3—melanoma	0.0027	0.00622	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Vemurafenib—melanoma	0.00266	0.0165	CcSEcCtD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—melanoma	0.00264	0.00607	CbGpPWpGaD
Bendroflumethiazide—Orthostatic hypotension—Docetaxel—melanoma	0.00264	0.0164	CcSEcCtD
Bendroflumethiazide—Rash—Vemurafenib—melanoma	0.00263	0.0163	CcSEcCtD
Bendroflumethiazide—Dermatitis—Vemurafenib—melanoma	0.00263	0.0163	CcSEcCtD
Bendroflumethiazide—Cramp muscle—Docetaxel—melanoma	0.0026	0.0161	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—BSG—melanoma	0.00259	0.00595	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IFNA5—melanoma	0.00251	0.00577	CbGpPWpGaD
Bendroflumethiazide—Nausea—Vemurafenib—melanoma	0.00248	0.0154	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Bleomycin—melanoma	0.00248	0.0154	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—UGT2B10—melanoma	0.00247	0.00569	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—FLNA—melanoma	0.00243	0.0056	CbGpPWpGaD
Bendroflumethiazide—Anorexia—Bleomycin—melanoma	0.00241	0.015	CcSEcCtD
Bendroflumethiazide—Hypotension—Bleomycin—melanoma	0.00236	0.0147	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Dactinomycin—melanoma	0.00231	0.0143	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CDKN2A—melanoma	0.00231	0.0053	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HS3ST5—melanoma	0.0023	0.00529	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—BCL2—melanoma	0.00227	0.00522	CbGpPWpGaD
Bendroflumethiazide—Anorexia—Dactinomycin—melanoma	0.00225	0.014	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—CLU—melanoma	0.0022	0.00506	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Bleomycin—melanoma	0.0022	0.0136	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CD4—melanoma	0.00217	0.005	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Carmustine—melanoma	0.00216	0.0134	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—PTGS2—melanoma	0.00216	0.00496	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—RHOB—melanoma	0.00215	0.00495	CbGpPWpGaD
Bendroflumethiazide—Anorexia—Carmustine—melanoma	0.00211	0.0131	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Temozolomide—melanoma	0.00209	0.013	CcSEcCtD
Bendroflumethiazide—Hypotension—Carmustine—melanoma	0.00206	0.0128	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Dactinomycin—melanoma	0.00205	0.0127	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CDKN1B—melanoma	0.00204	0.0047	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—FAS—melanoma	0.00204	0.00469	CbGpPWpGaD
Bendroflumethiazide—Anorexia—Temozolomide—melanoma	0.00203	0.0126	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—ACER3—melanoma	0.00196	0.0045	CbGpPWpGaD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CCND1—melanoma	0.00195	0.00448	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—RAC2—melanoma	0.00193	0.00444	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Carmustine—melanoma	0.00192	0.0119	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—VEGFC—melanoma	0.0019	0.00437	CbGpPWpGaD
Bendroflumethiazide—Constipation—Carmustine—melanoma	0.00189	0.0117	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—CDKN1A—melanoma	0.00188	0.00433	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ACER3—melanoma	0.00187	0.00431	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Temozolomide—melanoma	0.00186	0.0115	CcSEcCtD
Bendroflumethiazide—Constipation—Temozolomide—melanoma	0.00182	0.0113	CcSEcCtD
Bendroflumethiazide—Asthenia—Bleomycin—melanoma	0.00182	0.0113	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—ACER3—melanoma	0.0018	0.00413	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—CDK4—melanoma	0.00179	0.00413	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—UGT2B10—melanoma	0.00179	0.00411	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—NOS2—melanoma	0.00174	0.00401	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PLCB4—melanoma	0.00174	0.00401	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—UGT2B10—melanoma	0.00171	0.00394	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Dactinomycin—melanoma	0.00169	0.0105	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—NRAS—melanoma	0.00168	0.00386	CbGpPWpGaD
Bendroflumethiazide—Muscle spasms—Docetaxel—melanoma	0.00167	0.0104	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—SPARC—melanoma	0.00167	0.00384	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—F2R—melanoma	0.00167	0.00384	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HS3ST5—melanoma	0.00166	0.00382	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—PRKCA—melanoma	0.00166	0.00382	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—UGT2B10—melanoma	0.00164	0.00378	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC6A11—melanoma	0.00164	0.00377	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIP4K2A—melanoma	0.00164	0.00377	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—PPARG—melanoma	0.00163	0.00375	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Dactinomycin—melanoma	0.00161	0.01	CcSEcCtD
Bendroflumethiazide—Vomiting—Bleomycin—melanoma	0.00161	0.00998	CcSEcCtD
Bendroflumethiazide—Rash—Bleomycin—melanoma	0.0016	0.0099	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—HS3ST5—melanoma	0.00159	0.00367	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTAP—melanoma	0.00159	0.00367	CbGpPWpGaD
Bendroflumethiazide—Dermatitis—Bleomycin—melanoma	0.00159	0.00989	CcSEcCtD
Bendroflumethiazide—Asthenia—Carmustine—melanoma	0.00158	0.00983	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—MYC—melanoma	0.00156	0.00359	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HSPA5—melanoma	0.00156	0.00359	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Temozolomide—melanoma	0.00153	0.0095	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—HS3ST5—melanoma	0.00153	0.00352	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—GAB2—melanoma	0.00153	0.00351	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—GNA11—melanoma	0.00153	0.00351	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Carmustine—melanoma	0.00151	0.00938	CcSEcCtD
Bendroflumethiazide—Nausea—Bleomycin—melanoma	0.0015	0.00933	CcSEcCtD
Bendroflumethiazide—Vomiting—Dactinomycin—melanoma	0.0015	0.00931	CcSEcCtD
Bendroflumethiazide—Rash—Dactinomycin—melanoma	0.00149	0.00923	CcSEcCtD
Bendroflumethiazide—Dizziness—Carmustine—melanoma	0.00146	0.00906	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Temozolomide—melanoma	0.00146	0.00906	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—KRAS—melanoma	0.00144	0.00332	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HDAC2—melanoma	0.00143	0.0033	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—LUM—melanoma	0.00142	0.00327	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PHGDH—melanoma	0.00142	0.00327	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—GNAQ—melanoma	0.00142	0.00326	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ITGA4—melanoma	0.00142	0.00326	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—CD44—melanoma	0.00142	0.00326	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Temozolomide—melanoma	0.00141	0.00876	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—IFNB1—melanoma	0.00141	0.00324	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Carmustine—melanoma	0.0014	0.00871	CcSEcCtD
Bendroflumethiazide—Nausea—Dactinomycin—melanoma	0.0014	0.0087	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—HPSE—melanoma	0.00139	0.0032	CbGpPWpGaD
Bendroflumethiazide—Rash—Carmustine—melanoma	0.00139	0.00864	CcSEcCtD
Bendroflumethiazide—Dermatitis—Carmustine—melanoma	0.00139	0.00863	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Docetaxel—melanoma	0.00139	0.00862	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—IFNA1—melanoma	0.00137	0.00316	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CUBN—melanoma	0.00137	0.00315	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Temozolomide—melanoma	0.00136	0.00842	CcSEcCtD
Bendroflumethiazide—Anorexia—Docetaxel—melanoma	0.00135	0.00839	CcSEcCtD
Bendroflumethiazide—Rash—Temozolomide—melanoma	0.00135	0.00835	CcSEcCtD
Bendroflumethiazide—Dermatitis—Temozolomide—melanoma	0.00134	0.00834	CcSEcCtD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—melanoma	0.00134	0.00308	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SYK—melanoma	0.00133	0.00307	CbGpPWpGaD
Bendroflumethiazide—Hypotension—Docetaxel—melanoma	0.00133	0.00823	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—SDHD—melanoma	0.00132	0.00304	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CSPG4—melanoma	0.00132	0.00304	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—BSG—melanoma	0.00132	0.00304	CbGpPWpGaD
Bendroflumethiazide—Nausea—Carmustine—melanoma	0.00131	0.00814	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—ITGAV—melanoma	0.00131	0.00301	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT3—melanoma	0.00131	0.00301	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GPAM—melanoma	0.00128	0.00294	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IFNA2—melanoma	0.00128	0.00294	CbGpPWpGaD
Bendroflumethiazide—Nausea—Temozolomide—melanoma	0.00127	0.00787	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—PLCB4—melanoma	0.00126	0.0029	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—melanoma	0.00126	0.00289	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Docetaxel—melanoma	0.00123	0.00766	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—HRAS—melanoma	0.00123	0.00282	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—BRAF—melanoma	0.00122	0.00281	CbGpPWpGaD
Bendroflumethiazide—Constipation—Docetaxel—melanoma	0.00121	0.00753	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—PLCB4—melanoma	0.00121	0.00278	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ITGB1—melanoma	0.00119	0.00273	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC6A11—melanoma	0.00118	0.00272	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIP4K2A—melanoma	0.00118	0.00272	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PLCB4—melanoma	0.00116	0.00266	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTAP—melanoma	0.00115	0.00265	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC6A11—melanoma	0.00114	0.00261	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIP4K2A—melanoma	0.00114	0.00261	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—PTEN—melanoma	0.00112	0.00257	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTAP—melanoma	0.0011	0.00254	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIP4K2A—melanoma	0.00109	0.0025	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC6A11—melanoma	0.00109	0.0025	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PLA2G6—melanoma	0.00109	0.0025	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HGF—melanoma	0.00109	0.0025	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—CSF2—melanoma	0.00107	0.00247	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTAP—melanoma	0.00106	0.00244	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PRKCA—melanoma	0.00103	0.00237	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ITGB3—melanoma	0.00103	0.00237	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PHGDH—melanoma	0.00103	0.00236	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—LUM—melanoma	0.00103	0.00236	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—MDM2—melanoma	0.00102	0.00235	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—melanoma	0.00102	0.00235	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Docetaxel—melanoma	0.00102	0.00632	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—HPSE—melanoma	0.00101	0.00232	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CUBN—melanoma	0.000989	0.00227	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PHGDH—melanoma	0.000985	0.00227	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—LUM—melanoma	0.000985	0.00227	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—VCAN—melanoma	0.000977	0.00225	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Docetaxel—melanoma	0.000971	0.00603	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—HPSE—melanoma	0.000966	0.00222	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—RAC1—melanoma	0.000955	0.0022	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SDHD—melanoma	0.000955	0.0022	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CSPG4—melanoma	0.000955	0.0022	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—BSG—melanoma	0.000955	0.0022	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CUBN—melanoma	0.000948	0.00218	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—LUM—melanoma	0.000944	0.00217	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PHGDH—melanoma	0.000944	0.00217	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Docetaxel—melanoma	0.000938	0.00582	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—HPSE—melanoma	0.000926	0.00213	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GPAM—melanoma	0.000925	0.00213	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MMP1—melanoma	0.000924	0.00213	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SDHD—melanoma	0.000915	0.00211	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—BSG—melanoma	0.000915	0.00211	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CSPG4—melanoma	0.000915	0.00211	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CUBN—melanoma	0.000909	0.00209	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—CDK2—melanoma	0.000907	0.00209	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Docetaxel—melanoma	0.000902	0.0056	CcSEcCtD
Bendroflumethiazide—Rash—Docetaxel—melanoma	0.000895	0.00555	CcSEcCtD
Bendroflumethiazide—Dermatitis—Docetaxel—melanoma	0.000894	0.00555	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—GPAM—melanoma	0.000887	0.00204	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SDHD—melanoma	0.000878	0.00202	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—BSG—melanoma	0.000878	0.00202	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CSPG4—melanoma	0.000878	0.00202	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GPAM—melanoma	0.00085	0.00196	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—FN1—melanoma	0.000843	0.00194	CbGpPWpGaD
Bendroflumethiazide—Nausea—Docetaxel—melanoma	0.000843	0.00523	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—NOS2—melanoma	0.000833	0.00192	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP17A1—melanoma	0.000824	0.0019	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CG—melanoma	0.000807	0.00186	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—EGF—melanoma	0.000798	0.00183	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PLA2G6—melanoma	0.000786	0.00181	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GNA11—melanoma	0.000778	0.00179	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—melanoma	0.000763	0.00176	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—FASN—melanoma	0.000762	0.00175	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PLA2G6—melanoma	0.000754	0.00173	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SLC5A5—melanoma	0.000749	0.00172	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IGF1—melanoma	0.000739	0.0017	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GNAQ—melanoma	0.000724	0.00166	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CD44—melanoma	0.000724	0.00166	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PLA2G6—melanoma	0.000723	0.00166	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CD—melanoma	0.000709	0.00163	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—VCAN—melanoma	0.000706	0.00162	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ALB—melanoma	0.0007	0.00161	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—MAPK1—melanoma	0.000699	0.00161	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—melanoma	0.000699	0.00161	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYP1B1—melanoma	0.000694	0.0016	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—VCAN—melanoma	0.000677	0.00156	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—VCAN—melanoma	0.000649	0.00149	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—melanoma	0.000639	0.00147	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CB—melanoma	0.000618	0.00142	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP17A1—melanoma	0.000596	0.00137	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP17A1—melanoma	0.000571	0.00131	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCB1—melanoma	0.000571	0.00131	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IL2—melanoma	0.000568	0.00131	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GNA11—melanoma	0.000563	0.00129	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—HRAS—melanoma	0.000561	0.00129	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—FASN—melanoma	0.000551	0.00127	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP17A1—melanoma	0.000548	0.00126	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC5A5—melanoma	0.000542	0.00125	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GNA11—melanoma	0.00054	0.00124	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—FASN—melanoma	0.000528	0.00121	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PRKCA—melanoma	0.000526	0.00121	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GNAQ—melanoma	0.000523	0.0012	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CD44—melanoma	0.000523	0.0012	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ERCC2—melanoma	0.000521	0.0012	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC5A5—melanoma	0.000519	0.00119	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GNA11—melanoma	0.000517	0.00119	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—FASN—melanoma	0.000506	0.00116	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GNAQ—melanoma	0.000502	0.00115	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CD44—melanoma	0.000502	0.00115	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYP1B1—melanoma	0.000502	0.00115	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC5A5—melanoma	0.000498	0.00115	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—VEGFA—melanoma	0.000483	0.00111	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CD44—melanoma	0.000481	0.00111	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYP1B1—melanoma	0.000481	0.00111	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GNAQ—melanoma	0.000481	0.00111	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—NRAS—melanoma	0.000477	0.0011	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYP1B1—melanoma	0.000461	0.00106	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MAPK3—melanoma	0.000457	0.00105	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MAPK1—melanoma	0.000434	0.000999	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCB1—melanoma	0.000413	0.00095	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CG—melanoma	0.000412	0.000947	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—KRAS—melanoma	0.00041	0.000944	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PPARG—melanoma	0.000397	0.000914	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCB1—melanoma	0.000396	0.000911	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PRKCA—melanoma	0.00038	0.000874	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCB1—melanoma	0.00038	0.000873	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ERCC2—melanoma	0.000377	0.000867	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CA—melanoma	0.000377	0.000867	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TP53—melanoma	0.000365	0.000839	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PRKCA—melanoma	0.000364	0.000838	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CD—melanoma	0.000362	0.000833	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ERCC2—melanoma	0.000361	0.000831	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALB—melanoma	0.000357	0.000822	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PRKCA—melanoma	0.000349	0.000804	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HRAS—melanoma	0.000349	0.000802	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ERCC2—melanoma	0.000347	0.000797	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CB—melanoma	0.000316	0.000726	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTGS2—melanoma	0.000313	0.000719	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT1—melanoma	0.000308	0.000708	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CG—melanoma	0.000298	0.000685	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PPARG—melanoma	0.000287	0.000661	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CG—melanoma	0.000285	0.000657	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PPARG—melanoma	0.000276	0.000634	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CG—melanoma	0.000274	0.00063	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTEN—melanoma	0.000273	0.000627	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PPARG—melanoma	0.000264	0.000608	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CD—melanoma	0.000262	0.000602	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALB—melanoma	0.000258	0.000594	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CD—melanoma	0.000251	0.000577	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALB—melanoma	0.000248	0.00057	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CD—melanoma	0.000241	0.000553	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALB—melanoma	0.000238	0.000546	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CB—melanoma	0.000228	0.000525	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTGS2—melanoma	0.000226	0.00052	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CB—melanoma	0.000219	0.000503	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTGS2—melanoma	0.000217	0.000499	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CB—melanoma	0.00021	0.000482	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTGS2—melanoma	0.000208	0.000478	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTEN—melanoma	0.000197	0.000453	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CA—melanoma	0.000192	0.000443	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTEN—melanoma	0.000189	0.000435	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTEN—melanoma	0.000181	0.000417	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AKT1—melanoma	0.000157	0.000361	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CA—melanoma	0.000139	0.00032	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CA—melanoma	0.000133	0.000307	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CA—melanoma	0.000128	0.000294	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AKT1—melanoma	0.000114	0.000261	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AKT1—melanoma	0.000109	0.000251	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AKT1—melanoma	0.000104	0.00024	CbGpPWpGaD
